CMS Recognizes Specialist in Cytology Certification as CLIA Compliant

The ASCP and ASCP Board of Certification (BOC) are pleased to announce a significant milestone that underscores the value of ASCP BOC credentials in enhancing the professional landscape for laboratory professionals while elevating patient safety. The ASCP BOC developed an eligibility route for the SCT(ASCP) certification exam, specifically for graduates of master's level CAAHEP-accredited Cytology Programs within the past five years. 

This initiative, alongside a recent advocacy win with the Center for Medicare and Medicaid Services (CMS) and the Center for Disease Control and Prevention (CDC), highlights the BOC's commitment to advancing the cytology field. As of July 2024, CMS and the CDC have recognized the ASCP BOC Specialist in Cytology certification, SCT(ASCP), as an approved board examination for meeting the CLIA personnel qualifications of 42 CFR 493.1483.

This approval includes all SCT(ASCP) credential holders, including those who tested under Route 3 before July 2024, ensuring that all CT(ASCP) and SCT(ASCP) credential holders are recognized under the CLIA personnel qualifications. This significant achievement benefits all ASCP BOC credentialed cytologists and the patients they serve. 

For complete information on the CT(ASCP) and SCT(ASCP) credentials, eligibility requirements, and application instructions, visit the BOC website at www.ascp.org/boc/ct and www.ascp.org/boc/sct. We extend our gratitude to everyone who contributed to this advocacy win and to our community of cytology laboratory professionals for their dedication to excellence.

To read more articles from this issue of ePolicy, click here. To learn more about ePolicy News and access past newsletters and articles, click here.